Skip to main content

Whitehead Licenses Reverse Transfection Patent Rights to Corning

NEW YORK, Aug. 3 (GenomeWeb News) - The Whitehead Institute for Biomedical Research has granted Corning Life Sciences a license for the patent rights to its reverse transfection technology, Corning said yesterday.


Corningwill pair the microarray-based method for the functional analysis in mammalian cells of many genes in parallel with other technology to enhance its molecular and cell culture applications.


A spokesperson for the Whitehead said the technology could be useful in drug screening and development, though a representative from Corning declined to comment on possible future applications.


Financial details were not discussed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.